Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110

Schlüter L, Hansen KØ, Isaksson J, Andersen JH, Hansen EH, Kalinowski J, Schneider YK-H (2024)
Frontiers in Bioengineering and Biotechnology 12.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 2.58 MB
Autor*in
Schlüter, LauraUniBi ; Hansen, Kine Østnes; Isaksson, Johan; Andersen, Jeanette Hammer; Hansen, Espen Holst; Kalinowski, JörnUniBi; Schneider, Yannik Karl-Heinz
Abstract / Bemerkung
As the natural producer of acarbose,Actinoplanessp. SE50/110 has high industrial relevance. Like most Actinobacteria, the strain carries several more putative biosynthetic gene clusters (BGCs) to produce further natural products, which are to be discovered. Applying a metabolomics-guided approach, we tentatively identified five further compounds that are produced by the strain: watasemycin, thiazostatin, isopyochelin, pulicatin, and aerugine. A comparison of the genomic context allowed the identification of the putative BGC, which is highly similar to the watasemycin biosynthetic gene cluster ofStreptomyces venezuelae. In addition to the identified molecules, a thiazostatin-like compound was found. Isolation and structure elucidation with 1D and 2D NMR and HRMS were applied. The fraction containingm/z369.0929 [M + H]+comprised two highly similar compounds identified as thiazostatin D and thiazostatin E. The compounds possessed the same phenol–thiazole–thiazole molecular scaffold as the previously reported thiazostatin and watasemycin and have anti-proliferative activity against the breast adenocarcinoma cell line MCF7 and human melanoma cell line A2058, while no activity again the non-malignant immortalized fibroblast cell line MRC-5 was observed. We further showed that the manipulation of global transcriptional regulators, withsigH(ACSP50_0507) and anti-anti-σ factor codingACSP50_0284as an example, enabled the production manipulation of the 2-hydroxyphenylthiazoline family molecules. While the manipulation ofsigHenabled the shift in the peak intensities between the five products of this pathway,ACSP50_0284manipulation prevented their production. The production of a highly polar compound withm/z462.1643 [M + H]+and calculated elemental composition C19H27NO12was activated under theACSP50_0284expression and is exclusively produced by the engineered strain.
Stichworte
Actinobacteria; Actinoplanes sp. SE50/110; natural products; secondary metabolites; sigma factor; hydroxyphenylthiazoline; metabolomics
Erscheinungsjahr
2024
Zeitschriftentitel
Frontiers in Bioengineering and Biotechnology
Band
12
eISSN
2296-4185
Page URI
https://pub.uni-bielefeld.de/record/2994667

Zitieren

Schlüter L, Hansen KØ, Isaksson J, et al. Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110. Frontiers in Bioengineering and Biotechnology. 2024;12.
Schlüter, L., Hansen, K. Ø., Isaksson, J., Andersen, J. H., Hansen, E. H., Kalinowski, J., & Schneider, Y. K. - H. (2024). Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1497138
Schlüter, Laura, Hansen, Kine Østnes, Isaksson, Johan, Andersen, Jeanette Hammer, Hansen, Espen Holst, Kalinowski, Jörn, and Schneider, Yannik Karl-Heinz. 2024. “Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110”. Frontiers in Bioengineering and Biotechnology 12.
Schlüter, L., Hansen, K. Ø., Isaksson, J., Andersen, J. H., Hansen, E. H., Kalinowski, J., and Schneider, Y. K. - H. (2024). Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110. Frontiers in Bioengineering and Biotechnology 12.
Schlüter, L., et al., 2024. Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110. Frontiers in Bioengineering and Biotechnology, 12.
L. Schlüter, et al., “Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110”, Frontiers in Bioengineering and Biotechnology, vol. 12, 2024.
Schlüter, L., Hansen, K.Ø., Isaksson, J., Andersen, J.H., Hansen, E.H., Kalinowski, J., Schneider, Y.K.-H.: Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110. Frontiers in Bioengineering and Biotechnology. 12, (2024).
Schlüter, Laura, Hansen, Kine Østnes, Isaksson, Johan, Andersen, Jeanette Hammer, Hansen, Espen Holst, Kalinowski, Jörn, and Schneider, Yannik Karl-Heinz. “Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of Actinoplanes sp. SE50/110”. Frontiers in Bioengineering and Biotechnology 12 (2024).
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2024-11-26T09:23:08Z
MD5 Prüfsumme
6f75181ad76618218e1f83f456e0e297


Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 39654828
PubMed | Europe PMC

Suchen in

Google Scholar